Reproducibility and genital sparing with a vaginal dilator used for female anal cancer patients
Tài liệu tham khảo
1996, Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin, Lancet, 348, 1049, 10.1016/S0140-6736(96)03409-5
Flam, 1996, Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study, J Clin Oncol, 14, 2527, 10.1200/JCO.1996.14.9.2527
Bartelink, 1997, J Clin Oncol, 15, 2040, 10.1200/JCO.1997.15.5.2040
Ajani, 2008, Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial, Jama, 299, 1914, 10.1001/jama.299.16.1914
Allal, 1999, Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy, Br J Cancer, 80, 1588, 10.1038/sj.bjc.6690567
Vordermark, 1999, Curative-intent radiation therapy in anal carcinoma: quality of life and sphincter function, Radiother Oncol, 52, 239, 10.1016/S0167-8140(99)00096-1
Jephcott, 2004, Quality of life after non-surgical treatment of anal carcinoma: a case control study of long-term survivors, Clin Oncol (R Coll Radiol), 16, 530, 10.1016/j.clon.2004.05.007
Tournier-Rangeard, 2008, Radiochemotherapy of locally advanced anal canal carcinoma: prospective assessment of early impact on the quality of life (randomized trial ACCORD 03), Radiother Oncol, 87, 391, 10.1016/j.radonc.2007.12.004
Saarilahti, 2008, The effect of intensity-modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy-related adverse events following chemoradiotherapy of anal cancer, Radiother Oncol, 87, 383, 10.1016/j.radonc.2008.04.011
Das, 2010, Long-term quality of life after radiotherapy for the treatment of anal cancer, Cancer, 116, 822, 10.1002/cncr.24906
Salama, 2007, Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience, J Clin Oncol, 25, 4581, 10.1200/JCO.2007.12.0170
Kachnic, 2009, RTOG 0529: a phase II evaluation of dose-painted IMRT in combination with 5-fluorouracil and mitomycin-C for reduction of acute morbidity in carcinoma of the anal canal, Int J Radiat Oncol Biol Phys, 75, S5, 10.1016/j.ijrobp.2009.07.038
Kachnic, 2010, Early efficacy results of RTOG 0529: a phase II evaluation of dose-painted IMRT in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal, Int J Radiat Oncol Biol Phys, 78, S55, 10.1016/j.ijrobp.2010.07.162
Pepek, 2010, Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis, Int J Radiat Oncol Biol Phys, 78, 1413, 10.1016/j.ijrobp.2009.09.046
Bazan, 2011, Intensity-modulated radiation therapy versus conventional radiation therapy for squamous cell carcinoma of the anal canal, Cancer, 3342, 10.1002/cncr.25901
Kachnic, 2012, Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy, Int J Radiat Oncol Biol Phys, 82, 153, 10.1016/j.ijrobp.2010.09.030
Chen, 2005, Organ sparing by conformal avoidance intensity-modulated radiation therapy for anal cancer: dosimetric evaluation of coverage of pelvis and inguinal/femoral nodes, Int J Radiat Oncol Biol Phys, 63, 274, 10.1016/j.ijrobp.2005.05.052
Milano, 2005, Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome, Int J Radiat Oncol Biol Phys, 63, 354, 10.1016/j.ijrobp.2005.02.030
Mok, 2011, Comparative analysis of volumetric modulated arc therapy versus intensity modulated radiation therapy for radiotherapy of anal carcinoma, Prac Radiat Oncol, 1, 163, 10.1016/j.prro.2011.01.003
Ikushima, 2011, Daily alignment results of in-room computed tomography-guided stereotactic body radiation therapy for lung cancer, Int J Radiat Oncol Biol Phys, 79, 473, 10.1016/j.ijrobp.2009.11.009